ZEALAND PHARMA A/S Press release - No. 12 / 2017
Zealand Pharma to attend three U.S. healthcare conferences in December
Copenhagen, November 29, 2017 - Britt Meelby Jensen, President and Chief Executive Officer (CEO) and Mats Blom, Executive Vice President and Chief Financial Officer (CFO) of Zealand Pharma, will be present at the Carnegie Nordic Healthcare Day, New York, on Tuesday, December 5, 2017 and at the Citi Healthcare Conference, New York, on Wednesday, December 6, 2017.
Mats Blom, Executive Vice President and Chief Financial Officer (CFO) of Zealand Pharma, will be present at the Guggenheim Annual Boston Healthcare Conference, Boston, on Wednesday, December 13, 2017.
For further information, please contact:
Mats Blom, Executive Vice President and Chief Financial Officer
Tel.: +45 31 53 79 73, e-mail: mabl@zealandpharma.com
About Zealand Pharma A/S
Zealand Pharma A/S (Nasdaq Copenhagen and New York: ZEAL) ("Zealand") is a biotechnology company focused on the discovery, design and development of innovative peptide-based medicines. Zealand has a portfolio of medicines and product candidates under license collaborations with Sanofi and Boehringer Ingelheim as well as a pipeline of internal product candidates focusing on specialty gastrointestinal and metabolic diseases.
Zealand is based in Copenhagen (Glostrup), Denmark. For further information about the Company's business and activities, please visit www.zealandpharma.com or follow Zealand on LinkedIn or Twitter @ZealandPharma.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Zealand Pharma via Globenewswire
